|
|
 |
|
CADX: Cadence Pharmaceuticals Inc - Stock News |
Enter Ticker:
|
|
| Nov 16, 2009 |
Cadence Pharma (CADX) Downgrade Alert, Watch for 7.2% Technical Downtrend Continuation |
| Nov 16, 2009 |
Analyst Downgrades for November 16th |
| Nov 13, 2009 |
CADX: CEO Comments on FDA's Extension of PDUFA Date for IV Acetaminophen |
| Nov 13, 2009 |
CADX: Extension of PDUFA Date for Intravenous Acetaminophen by 3 Months |
| Nov 13, 2009 |
Crown Equity Holdings, Inc.: CRWENews Highlights: SORL, CADX, CNGL |
| Nov 13, 2009 |
CADX: Conference call regarding Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months @ 08:30 ET Today [delayed] |
| Nov 13, 2009 |
Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months |
| Nov 12, 2009 |
Cadence Pharmaceuticals Down 4.4% Since SmarTrend's Sell Recommendation |
| Nov 05, 2009 |
Cadence Pharmaceuticals Reports Third Quarter 2009 Financial Results |
| Oct 29, 2009 |
Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5, 2009 |
| Oct 28, 2009 |
Cadence Pharmaceuticals' CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009 |
| Oct 28, 2009 |
Cadence Pharmaceuticals Down 3.2% Since SmarTrend's Sell Recommendation |
| Oct 20, 2009 |
Cadence Pharmaceuticals' CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009 |
| Oct 06, 2009 |
Conference Calls Today: 2-2:30 P.M. EDT |
| Oct 05, 2009 |
Cadence Pharmaceuticals, Inc. (CADX) President, CEO and Director to Ring The NASDAQ Stock Market Opening Bell |
| |
| ZACKS COMMENTARY FOR CADX |
|
|
|
Sponsored Links 
0.02